
Senate Bill May Allow Overseas Prescription Imports
Senators Byron Dorgan (D-ND), Olympia Snow (R-ME), John McCain (R-AZ), and Debbit Stabenow (D-MI) introduced a bill March 4 that would allow pharmacists and wholesalers to import prescription drugs from Australia, New Zealand, Japan, Switzerland and the European Union.
Senators Byron Dorgan (D-ND), Olympia Snow (R-ME), John McCain (R-AZ), and Debbie Stabenow (D-MI) introduced a bill on Mar. 4, 2009, that would allow pharmacists and wholesalers to import prescription drugs from Australia, New Zealand, Japan, Switzerland, and the European Union. The bill’s cosponsors claim that Americans pay as much as 5 times more to fill their prescriptions than consumers in other countries and that “promoting competitive market pricing would both contribute to healthcare savings and allow greater access to therapy.”
If the bill,
The bill does not apply to controlled substances, biologics, infused or injected drugs, drugs inhaled during surgery, and sterile ophthlamic drugs intended for topical or eye use. In addition, a drug that is referred to in two or more abbreviated new drug applications cannot be imported under the new proposed legislation.
Although patients may be happy with the proposed legislation, industry has voiced concern over the bill. “It is critical that we maintain our focus on comprehensive health reform to help all Americans access high-quality and affordable healthcare coverage,” said the Pharmaceutical Research and Manufacturers of America in a Mar. 4, 2009,
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





